NFE2L2 and Parkinson disease: Therefore, NFE2L2 and its signaling pathway have become a major therapeutic target for the treatment of diseases such as AD, PD, ALS, HD, and FA, which focuses on improving mitochondrial bioenergetics and function through the alleviation of oxidative stress and the activation of antioxidant defense [34, 115, 285].